ASCO 2015: Pre-conference review
This article was originally published in Scrip
In this roundtable The Pink Sheet’s Mary Jo Laffler talks to experts from Datamonitor Healthcare, Citeline and BioMedTracker about their top picks from this year's ASCO abstracts, as well as other news to watch out for at the 2015 conference at the end of this month.
They discuss highlights in the area of immune-oncology, specifically new combination drug candidates; game-changing data expected for myeloma therapies; how companies are looking at new approaches for old targets in oncology; and more.
For more coverage on ASCO 2015: